New! Sign up for our email newsletter on Substack.

How NOV-002 treatment leads to gene expression

HOW NOV-002 treatment leads to gene expression changes in SKOV3 cancer cell lines
———-

NADPH oxidase genes are up-regulated by chronic NOV-002 treatment in SKOV3 cells

NOX5 – 13.3 fold NADPH oxidase, EF calcium binding domain 5
– produces superoxide
– activated by calcium

CYBA – 2.1 fold – Cytochrome b-245 alpha polypeptide; p22 PHOX
– 22 KD subunit of NADPH oxidase
– produces superoxide anion

NCF – 2.1 fold – Neutrophil cytosolic factor 1: p47 PHOX; NOX02
– 67 KD subunit of NADPH oxidase
– produces superoxide anion
———————————–
Other genes that are up-regulated by chronic NOV-002 treatment in SKOV3 cells

IL8 – 39 fold – interleukin 8
– CXC chemokine; medicator of inflammatory response
– Chemoatrractrant and angiogenic factor
– Induced by oxidative stress

VEGFA – 3.5 fold – Vascular endothelial growth factor A
– Angiogenic factor
– Induced by oxidative stress
– Activates NADPH oxidase resulting in superoxide production

JUN – 1.8 fold – Jun oncogenes
– Activation can lead to Apoptosis

There's no paywall here

If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resourcesโ€”your support ensures we can keep uncovering the stories that matter most to you.

Join us in making knowledge accessible and impactful. Thank you for standing with us!



Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.